The in Vivo Significance of T Cells in Coxsackievirus B3 Myocarditis

T 细胞在柯萨奇病毒 B3 心肌炎中的体内意义

基本信息

  • 批准号:
    01570478
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1990
  • 项目状态:
    已结题

项目摘要

Acute myocardial damage similar to that seen in human myocarditis occurs in BALB/c mice after infection with Coxsackievirus B3 (CB3) or Encephalo-Myocarditis Virus (EMV). To investigate the role of antigen-specific T cells in the pathogenesis of this disorder, we compared CB3 disease expression in T cell-deficient, athymic nude (nu/nu) mice, in heterozygote (nu+) mice with normal T cell function, and in nu/nu mice reconstituted with spleen cells from CB3- or EMV-infected nu/+mice. Acute myocarditis occurred in both nu/nu and nu/+ mice, Severe myocarditis, however, developed only in nu/+ and nu/nu/nu mice reconstituted with CB3-sensitized T cells, but not in those reconstituted with EMC-sensitized T cells. Myocardial virus titer and serum anti-CB3 antibody production were similar in nu/+ and nu/nu groups. Additionally, the presence of Thy 1.2 (pan T), Ly 1 (precursor of other T cell subsets), and Ly 2 (suppressor/cytotoxic T) positive cells was demonstrated in the myocardium in nu/+ and … More nu/nu mice reconstituted with CB3-sensitized T cells, but not with T cells sensitized by another virus, EMC. These results indicate that immature but antigen-specific T cells play a role in the pathogesis of ongoing myocarditis.To test the effects of interleukinー2 (IL-2) upon CB3 myocarditis recombinant human IL-2, 5x10^4U, was administered subcutaneously daily starting on day O and on day 7 for 7 days, respectively. The treated groups were compared to infected controls. As a result, IL-2 has differential effects upon CB3 myocarditis ; IL-2 has the potency to limit CB3 myocarditis in the acute viremic stage, but it aggravates the course and the severity of the disease in the subacute a viremic stage by T cell activation. Also, FK-506, a novel immunosuppressant, induced immunosuppression in CB3 myocarditis, associated with a high mortality, notwithstanding the reduction of cardiac pathology.In addition, Fc receptor-mediated CB3 infection in vitro and in vivo was demonstrated in this murine model. Less
BALB/c小鼠感染柯萨奇病毒B3(CB 3)或脑心肌炎病毒(EMV)后,出现与人类心肌炎相似的急性心肌损伤。为了研究抗原特异性T细胞在这种疾病的发病机制中的作用,我们比较了T细胞缺陷的无胸腺裸小鼠(nu/nu),具有正常T细胞功能的杂合子(nu+)小鼠,以及用来自CB 3或EMV感染的nu/+小鼠的脾细胞重建的nu/nu小鼠中CB 3疾病的表达。nu/nu和nu/+小鼠均发生急性心肌炎,但严重心肌炎仅发生在用CB 3致敏的T细胞重建的nu/+和nu/nu/nu小鼠中,而不发生在用EMC致敏的T细胞重建的小鼠中。心肌病毒滴度和血清抗CB 3抗体的产生在nu/+和nu/nu组中相似。此外,在nu/+和nu/+的心肌中证实了Thy 1.2(pan T)、Ly 1(其他T细胞亚群的前体)和Ly 2(抑制/细胞毒性T)阳性细胞的存在。 ...更多信息 nu/nu小鼠用CB 3致敏的T细胞重建,但不用另一种病毒EMC致敏的T细胞重建。为了检测白细胞介素2(IL-2)对CB 3心肌炎的作用,分别从第0天和第7天开始每天皮下注射重组人IL-2,5 × 104 U,持续7天。将治疗组与感染对照组进行比较。结果,IL-2对CB 3心肌炎具有不同的作用; IL-2具有在急性病毒血症阶段限制CB 3心肌炎的效力,但它通过T细胞活化在亚急性病毒血症阶段加重疾病的病程和严重程度。此外,FK-506,一种新的免疫抑制剂,诱导免疫抑制CB 3心肌炎,与高死亡率,尽管减少心脏病理。此外,Fc受体介导的CB 3感染在体外和体内在这个小鼠模型中得到证实。少

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CHIHARU KISHIMOTO et al.: "Immunological mechanisms in experimental coxsakievirus B3 mycarditis in mice" Japanese Circulation Journal.
CHIHARU KISHIMOTO 等人:“小鼠实验性柯萨奇病毒 B3 心肌炎的免疫学机制”日本循环杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
CHIHARU KISHIMOTO et al.: "Antibodyーenhanced infection by coxsackievirus B3 via Fc receptor in vitro and in vivo:A possible mechanism of chronic active myocarditis" Circulation.
CHIHARU KISHIMOTO 等人:“体外和体内柯萨奇病毒 B3 通过 Fc 受体增强抗体感染:慢性活动性心肌炎的可能机制”循环。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
CHIHARU KISHIMOTO et al.: "The in vivo significance of T cells in the development of coxsackievirus B3 myocarditis" Science.
CHIHARU KISHIMOTO 等人:“T 细胞在柯萨奇病毒 B3 心肌炎发展中的体内意义”《科学》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
岸本 千晴,篠山 重威,落合 宏: "免疫学的心筋細胞障害 シンポジウムII「心筋細胞障害の成因」" Japanese Circulation Journal. 54(Suppl 1). 47- (1990)
Chiharu Kishimoto、Shigetake Shinoyama、Hiroshi Ochiai:“免疫学心肌细胞损伤研讨会 II“心肌细胞损伤的原因”日本循环杂志。54(增刊 1)。47-(1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
YUJI HIRAOKA et al.: "The effects of FKー506,a nover and potent immunoーsuppressant ,upon murine coxsackievirus B3 myocarditis" Journal of Antibiotics.
YUJI HIRAOKA 等人:“FK-506(一种新颖且有效的免疫抑制剂)对小鼠柯萨奇病毒 B3 心肌炎的影响”《抗生素杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KISHIMOTO Chiharu其他文献

KISHIMOTO Chiharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KISHIMOTO Chiharu', 18)}}的其他基金

Myocardial regeneration by redox regulation in myocarditis with heart failure
心力衰竭心肌炎中氧化还原调节的心肌再生
  • 批准号:
    18590772
  • 财政年份:
    2006
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Treatment for myocarditis with heart failure by the inhibitory Fc receptor of immunoglobulin
免疫球蛋白抑制性Fc受体治疗心肌炎心力衰竭
  • 批准号:
    14570656
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analyses of myocardial epitopes and apoptosis with treatment of peptide therapy in myocarditis.
心肌炎肽疗法治疗心肌表位和细胞凋亡的分析。
  • 批准号:
    09470164
  • 财政年份:
    1997
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Myocardial damage by cultured autologous lymphocytes with IL-2 in viral myocarditis
IL-2培养自体淋巴细胞对病毒性心肌炎的心肌损伤
  • 批准号:
    06670702
  • 财政年份:
    1994
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Antibody-mediated infection and cytotoxic T cells in cosackievirus B3 myocarditis
科萨基病毒 B3 心肌炎中抗体介导的感染和细胞毒性 T 细胞
  • 批准号:
    03670445
  • 财政年份:
    1991
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Role of Natural Killer Cells in Myocarditis and Dilated Cardiomyopathy
自然杀伤细胞在心肌炎和扩张型心肌病中的作用
  • 批准号:
    8544199
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
Role of Natural Killer Cells in Myocarditis and Dilated Cardiomyopathy
自然杀伤细胞在心肌炎和扩张型心肌病中的作用
  • 批准号:
    8400774
  • 财政年份:
    2012
  • 资助金额:
    $ 1.34万
  • 项目类别:
Analysis of Left Ventricular Remodeling and Hemodynamics in Dilated Cardiomyopathy and Myocarditis and Application for Regeneration Therapy
扩张型心肌病和心肌炎的左心室重构和血流动力学分析及再生治疗的应用
  • 批准号:
    16590678
  • 财政年份:
    2004
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene expression in myocarditis and dilated cardiomyopathy and basic study of gene therapy by plasmid
心肌炎和扩张型心肌病基因表达及质粒基因治疗基础研究
  • 批准号:
    14570645
  • 财政年份:
    2002
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Viral infection and Cardiomyopathy: enteroviral Replication and Cardiocyte Injury in the Recipient Hearts of Dilated Cardiomyopathy and Perforin Knockout Mice with Viral Myocarditis
病毒感染与心肌病:扩张型心肌病和穿孔素敲除小鼠病毒性心肌炎受体心脏中的肠道病毒复制和心肌细胞损伤
  • 批准号:
    13670757
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Disruption of natural healing process in autoimmune myocarditis and progression to dilated cardiomyopathy
自身免疫性心肌炎自然愈合过程的破坏和扩张型心肌病的进展
  • 批准号:
    12670653
  • 财政年份:
    2000
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study on the mechanism of myocardial injury in myocarditis and dilated cardiomyopathy.
心肌炎和扩张型心肌病心肌损伤机制的研究。
  • 批准号:
    11670714
  • 财政年份:
    1999
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of the Specific Immunotherapy for Myocarditis, Dilated Cardiomyopathy(Chronic Myocarditis), and Takayasu Arteritis.
心肌炎、扩张型心肌病(慢性心肌炎)、大动脉炎的特异性免疫疗法的开发。
  • 批准号:
    11557048
  • 财政年份:
    1999
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Chronic myocarditis as a causative factor that may potentially lead to dilated cardiomyopathy
慢性心肌炎是可能导致扩张型心肌病的致病因素
  • 批准号:
    10670682
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enteroviral Replication and Cardiocyte Injury in the Myocardium from patients with Dilated Cardiomyopathy and Perforin Knockout Mice with Viral Myocarditis
扩张型心肌病患者和穿孔素敲除病毒性心肌炎小鼠心肌中的肠道病毒复制和心肌细胞损伤
  • 批准号:
    10670681
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了